Form 8-K - Current report:
SEC Accession No. 0000950123-10-062799
Filing Date
2010-06-30
Accepted
2010-06-30 16:33:09
Documents
1
Period of Report
2010-06-29
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c03024e8vk.htm 8-K 9231
  Complete submission text file 0000950123-10-062799.txt   11109
Mailing Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 415-283-2200
VIA Pharmaceuticals, Inc. (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27264 | Film No.: 10927516
SIC: 2836 Biological Products, (No Diagnostic Substances)